ArticleCancer chemotherapy and pharmacology2021

Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients.

Anna P Sokolenko et al.PubMed ↗Publisher ↗

No numbers read from the abstract.